Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors
暂无分享,去创建一个
B. Gyawali | T. Choueiri | E. D. de Vries | G. Curigliano | C. Nabhan | D. Trapani | S. Gulati | Wenxin Xu | C. Labaki | G. Utkan | Y. Ürün | E. Yekedüz